Two antigenic types of fimbriae, serotypes 2 and 6, have been isolated from the gram-negative pathogen Bordetella pertussis. Serotype 2 fimbriae, which have a monomeric subunit molecular mass of 22 kilodaltons (2, 25) , and serotype 6 fimbriae, which have a slightly different molecular mass of 21.5 kilodaltons (6) , are antigenically distinct since they are serotype-specific agglutinogens and polyclonal antibodies to type 2 fimbriae are only weakly cross-reactive with type 6 fimbriae (6). However, type 2 and type 6 fimbriae are similar in structure since they have an NH2-terminal amino acid sequence homology of about 75% (6, 16) and electron microscopic analysis has demonstrated that they have identical helical structures (21) . Little is known about the function of B. pertussis fimbriae, although there is some evidence which suggests that they mediate the adherence of the bacteria to tissue culture cells (10) , and there is considerable evidence demonstrating that fimbriae mediate the adherence of other microorganisms to host tissues (3, 4) . There is evidence that purified fimbriae can protect mice against lethal infection with B. pertussis (19, 26) .
In this study, a number of agglutinating monoclonal antibodies were identified and shown to be reactive with either type 2 or type 6 fimbriae of B. pertussis. It was demonstrated that these monoclonal antibodies recognize epitopes found only on partially or fully assembled fimbriae and that some of the antibodies recognize a similar antigen on certain strains of B. bronchiseptica.
MATERIALS AND METHODS
Microorganisms. Cells of Bordetella species were cultured on plates of Bordet-Gengou agar medium (Difco Laborato-* Corresponding author. (6, 25) . These crude fimbrial preparations were used for production of hybridomas and in an indirect enzyme-linked immunosorbent assay (ELISA). Further purification of fimbriae was performed as previously described (6, 25 The purity of immunoglobulin in pooled fractions was assessed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), and the immunoglobulin isotype was determined by ELISA with specific anti-mouse immunoglobulin reagents (Southern Biotechnology Associated, Inc., Birmingham, Ala.).
SDS-PAGE and Western blot (immunoblot) analysis. Fimbriae were solubilized in SDS-containing electrophoresis buffer in the presence of 0.1 M dithiothreitol and analyzed by SDS-PAGE without prior boiling of the sample. When separated on a 4 to 15% SDS gradient gel with a 3% stacking gel (12) , this resulted in the appearance of multiple bands, all larger than the monomeric fimbrial subunit as detected by staining of the gel with silver (24) or by Western blot analysis with the monoclonal antibodies (5) . Under these conditions, a significant portion of the fimbriae also does not enter the resolving gel.
ELISA. An ELISA was used to compare the reactivity of U.S. Reference Factor 2 or 6 antiserum (Eldering agglutinogen 2 or 6 polyclonal antiserum) with the antigen(s) recognized by the monoclonal antibodies. The wells of microtiter plates were coated overnight with 10 ,ug of purified monoclonal antibody, and after the plates were washed, crude outer membrane preparations (0.002 to 5 ,ug of protein per well) were added to the wells for 3 h at 25°C. The wells were washed, incubated overnight at 25°C with U.S. Reference Factor 2 antiserum (1:1,000) or Factor 6 antiserum (1:100), and the plates were developed with alkaline phosphatase conjugated to goat anti-rabbit immunoglobulin G (Sigma Chemical Co., St. Louis, Mo.) diluted 1:1,000, followed by Sigma 104 alkaline phosphatase substrate (17) .
Fluorescent staining and immunogold electron microscopy.
Indirect immunofluorescence and immunogold electron microscopy were performed essentially as described elsewhere (5), with formaldehyde-fixed bacteria and purified monoclonal antibody. Cells were labeled for immunogold electron microscopy with a 1:2 dilution of gold-conjugated goat anti-mouse immunoglobulin (10 nM; Boehringer Mannheim Biochemicals, Indianapolis, Ind.), and after three washes with phosphate-buffered saline ( (Fig. 1) . Monoclonal antibody BPF2 bound to 325 (serotype 1.2.3.4) cells (Fig. 1A) but not to 114 (serotype 1.3.6) cells (Fig. 1B) , while monoclonal antibody BPC10 bound only to 114 cells (Fig. 1D) . The other monoclonal antibodies demonstrated similar serotype-specific cell binding, as determined by the fluorescent-antibody technique. Immunogold electron microscopy also demonstrated that the monoclonal antibodies bind to a surface antigen on serotypespecific strains (Fig. 2) . A pattern consistent with the multiple labeling of fimbriae was observed on the surface of B. pertussis 325 cells reacted with BPF2 ( Fig. 2A) , but no labeling of 114 cells was detected with the BPF2 antibody (data not shown). In contrast, discrete clusters of bound gold particles extending from the surface of the cells were apparent when 114 cells were reacted with BPC10 (Fig. 2B) , but no binding of this antibody to 325 cells was observed (Fig.  2C) .
Western blot analysis of fimbriae. Previously it has been shown that type 2 and type 6 fimbriae have monomeric type-specific fimbriae by ELISA, none of the antibodies reacted with the monomeric fimbrial subunits on Western blots (data not shown). However, when purified nonboiled fimbriae were electrophoresed on a 4 to 15% SDS gradient gel, several repeating oligomeric bands, with a minimum molecular mass band of about 34 kilodaltons, were observed on a filter containing type 2 fimbriae detected with BPF2 (Fig. 3, lane 1) . A similar banding pattern was observed on a filter containing type 6 fimbriae and probed with BPC10 (Fig.  3, lane 3) . Only slight differences in the banding patterns were observed for the two types of fimbriae, but BPF2 did not react with the type 6 fimbriae (Fig. 3, lane 4) and BPC10 did not recognize type 2 fimbriae (Fig. 3, lane 2) . Monoclonal antibodies BPD5 and BPE6 gave a similar laddering pattern when reacted with type 2 fimbriae, and BPB7, BPD4, BPD6, BPD9, and BPF5 were similar to BPC10 in that they recognized only purified type 6 fimbriae (data not shown).
Fimbrial antigens recognized by U.S. Reference Factor antisera. Previous studies have identified B. pertussis fimbriae as serotype 2 and serotype 6 agglutinogens as defined by U.S. Reference Factor antisera (Eldering agglutinogen polyclonal antisera) (6, 25) . This correlation was verified by incubating crude fimbrial preparations with purified monoclonal antibodies bound to microtiter wells and detecting the bound antigen with U.S. Reference Factor antisera (Fig. 4) . U.S. Reference Factor 2 antiserum specifically recognized the antigen bound by monoclonal antibody BPD5 only when crude extracts from 325 cells (serotype 1.2.3.4) that contain agglutinogen 2 were used in the assay (Fig. 4A) . Likewise, U.S. Reference Factor 6 antiserum specifically detected the antigen bound by BPC10 only when preparations from 114 cells (serotype 1.3.6) containing agglutinogen 6 were incubated with the monoclonal antibodies (Fig. 4D) . No evidence for cross-reactivity of the polyclonal antisera or the monoclonal antibodies with unrelated fimbrial agglutinogens was observed in this assay. Also, no reactivity was observed when cell surface preparations from BP353 cells (serotype 1.3) which lack fimbriae were used in this sandwich ELISA (Fig. 4E and F) . Recognition of cross-reactive antigens on B. bronchiseptica cells. Fimbriae have been identified on B. bronchiseptica, and some cross-reactivity with B. pertussis fimbriae has been observed (6, 13 The monoclonal antibodies all reacted with native typespecific fimbriae as determined by ELISA and dot blot analysis but not with the monomeric fimbrial subunits. The antibodies also detected repeating oligomeric bands on Western blots containing purified, nonboiled, type-specific fimbriae separated by SDS-PAGE. Apparently the monoclonal antibodies recognize conformational epitopes present on oligomeric fimbrial units that are not present on fully denatured monomeric subunits. Monoclonal antibodies to Escherichia coli fimbriae have also been shown to react only with intact fimbriae (20) . The laddering pattern observed on
Western blots can also be demonstrated when crude fimbrial preparations produced by mechanical shearing or extraction of the cells with 4 M urea are analyzed by this method. This procedure should be useful for determining whether certain strains of B. pertussis express fimbriae and for identifying antibodies reactive with native fimbriae present on other microorganisms.
Some, but not all, of the monoclonal antibodies to both type 2 and type 6 fimbriae agglutinated or bound to (or both) B. bronchiseptica 106 and 11OH. Also, monoclonal antibodon November 6, 2017 by guest http://iai.asm.org/ Downloaded from ies BPB7, BPD6, and BPD9, to type 6 fimbriae only, agglutinated and bound to B. bronchiseptica 209 cells. This indicates that B. bronchiseptica cells synthesize fimbriae which contain antigenic sites similar to those found on type 2 and type 6 fimbriae of B. pertussis, as previously suggested (6, 13) . U.S. Reference Factor 2 and 6 antisera do not agglutinate B. bronchiseptica cells, but since these sera were adsorbed with specific strains of Bordetella species, including B. bronchiseptica (7), they could have been depleted of cross-reactive fimbrial antibodies. Further work is required to define the relationship between fimbriae of B. pertussis and fimbriae expressed by B. bronchiseptica.
In summary, the monoclonal antibodies described in this study should be useful for further structural analysis of B. pertussis fimbriae and the antigenically related fimbriae on B. bronchiseptica and to study the potential role of these fimbriae in adherence (10) . Together with other monoclonal antibodies to agglutinogens (5, 14) , they may also be useful as diagnostic probes for confirming the presence of serotypespecific B. pertussis cells in clinical isolates and for establishing a better-defined serotyping system for Bordetella species. In addition, the antibodies can be used in passive immunization studies to investigate the role of fimbriae as protective antigens.
